Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Liu Q, Zhao JN, Fang ZT, Wang X, Zhang BG, He Y, et al
We also acknowledge the technical assistance of Marie-Emmanuelle Goriot (IRBA U.TCT) and Denis Clay (INSERM UMS-44 Universit de Paris-Saclay, Villejuif) for flow cytometry cellular sorting
Dulaglutide is approved for T2DM management (Sanford, 2014), offering glycemic control and weight loss benefits comparable to liraglutide but with the added convenience of a weekly dosing regimen ( Semaglutide, another modified analog of human GLP-1, is resistant to DPP-4 degradation, which enables a once-weekly injection (Lau et al., 2015)
)
Liang X, Zhang Y, Lin F, et al
